S. Paglialunga

713 total citations
25 papers, 530 citations indexed

About

S. Paglialunga is a scholar working on Health, Toxicology and Mutagenesis, Molecular Biology and Cancer Research. According to data from OpenAlex, S. Paglialunga has authored 25 papers receiving a total of 530 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Health, Toxicology and Mutagenesis, 7 papers in Molecular Biology and 6 papers in Cancer Research. Recurrent topics in S. Paglialunga's work include Carcinogens and Genotoxicity Assessment (6 papers), Chromium effects and bioremediation (4 papers) and Analytical Chemistry and Chromatography (3 papers). S. Paglialunga is often cited by papers focused on Carcinogens and Genotoxicity Assessment (6 papers), Chromium effects and bioremediation (4 papers) and Analytical Chemistry and Chromatography (3 papers). S. Paglialunga collaborates with scholars based in Italy, United States and Guinea. S. Paglialunga's co-authors include Gerald N. Wogan, Paul M. Newberne, A.G. Levis, A. Montaldi, Vera Bianchi, Lorena Zentilin, A. Jori, G Prinò, Paola Venier and Michael C. Archer and has published in prestigious journals such as Journal of Chromatography A, Life Sciences and European Journal of Pharmacology.

In The Last Decade

S. Paglialunga

25 papers receiving 480 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Paglialunga Italy 13 210 195 142 131 59 25 530
John P. Frawley United States 14 110 0.5× 223 1.1× 181 1.3× 94 0.7× 51 0.9× 30 723
K. Tutikawa Japan 11 201 1.0× 76 0.4× 154 1.1× 221 1.7× 45 0.8× 18 596
W. B. Deichmann United States 14 172 0.8× 80 0.4× 167 1.2× 105 0.8× 48 0.8× 46 589
Tsutomu Yamaha Japan 14 123 0.6× 73 0.4× 241 1.7× 208 1.6× 39 0.7× 57 658
Luigi Sciabà Italy 11 240 1.1× 83 0.4× 80 0.6× 226 1.7× 49 0.8× 21 583
Martina Somorovská Slovakia 4 394 1.9× 150 0.8× 263 1.9× 270 2.1× 35 0.6× 4 835
A. Pino Italy 13 241 1.1× 125 0.6× 124 0.9× 216 1.6× 44 0.7× 27 550
Kaoru Sekihashi Japan 8 260 1.2× 198 1.0× 174 1.2× 181 1.4× 46 0.8× 10 568
T Szymczyk Poland 11 120 0.6× 117 0.6× 44 0.3× 131 1.0× 51 0.9× 23 356
K. L. Cheever United States 12 142 0.7× 127 0.7× 175 1.2× 75 0.6× 25 0.4× 21 428

Countries citing papers authored by S. Paglialunga

Since Specialization
Citations

This map shows the geographic impact of S. Paglialunga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Paglialunga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Paglialunga more than expected).

Fields of papers citing papers by S. Paglialunga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Paglialunga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Paglialunga. The network helps show where S. Paglialunga may publish in the future.

Co-authorship network of co-authors of S. Paglialunga

This figure shows the co-authorship network connecting the top 25 collaborators of S. Paglialunga. A scholar is included among the top collaborators of S. Paglialunga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Paglialunga. S. Paglialunga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Argalia, Giulio, et al.. (1995). [Echo-Doppler in chronic kidney transplant rejection. The diagnostic prospects using indices of the ascending systolic phase].. PubMed. 90(3). 272–7. 1 indexed citations
2.
Marco, Antonio De, et al.. (1988). Induction of micronuclei in Vicia faba root tips treated with heavy metals (cadmium and chromium) in the presence of NTA. Mutation Research/Genetic Toxicology. 206(3). 311–315. 19 indexed citations
3.
Lanfranchi, Gerolamo, S. Paglialunga, & A.G. Levis. (1988). Mammalian cell transformation induced by chromium(vi) compounds in the presence of nitrilotriacetic acid. Journal of Toxicology and Environmental Health. 24(2). 251–260. 13 indexed citations
4.
Montaldi, A., Lorena Zentilin, S. Paglialunga, & A.G. Levis. (1987). Solubilization by nitrilotriacetic acid (NTA) of genetically active Cr(VI) and Pb(II) from insoluble metal compounds. Journal of Toxicology and Environmental Health. 21(3). 387–394. 12 indexed citations
5.
Montaldi, A., Lorena Zentilin, Mauro Agostino Zordan, et al.. (1987). Chromosomal effects of heavy metals (Cd, Cr, Hg, Ni and Pb) on cultured mammalian cells in the presence of nitrilotriacetic acid (NTA). Toxicological & Environmental Chemistry Reviews. 14(3). 183–200. 17 indexed citations
6.
Venier, Paola, A. Montaldi, Lorena Zentilin, et al.. (1985). Effects of nitrilotriacetic acid on the induction of gene mutations and sister-chromatid exchanges by insoluble chromium compounds. Mutation Research/Genetic Toxicology. 156(3). 219–228. 31 indexed citations
7.
Montaldi, A., Lorena Zentilin, Paola Venier, et al.. (1985). Interaction of nitrilotriacetic acid with heavy metals in the induction of sister chromatid exchanges in cultured mammalian cells. Environmental Mutagenesis. 7(3). 381–390. 31 indexed citations
8.
Loprieno, N., Paola Venier, A. Montaldi, et al.. (1985). Increased mutagenicity of chromium compounds by nitrilotriacetic acid. Environmental Mutagenesis. 7(2). 185–200. 25 indexed citations
9.
Tortoreto, Monica, et al.. (1983). Determination of 4,4′-diaminodiphenylmethane in blood by gas—liquid chromatography with electron-capture detection. Journal of Chromatography A. 262. 367–372. 20 indexed citations
10.
Petrocellis, Luciano De, et al.. (1982). Determination of epichlorohydrin in blood by gas chromatography and selected ion monitoring. Journal of Chromatography A. 240(1). 218–223. 6 indexed citations
11.
Guaitani, A., L. Morasca, Giovanna Balconi, et al.. (1977). The influence of dietary yeast grown on n-Paraffins on mammary tumours induced bY 7,12-dimethylbenzanthracene and 3-methylcholanthrene in rats. Toxicology Letters. 1(3). 157–168. 1 indexed citations
12.
Busby, William F., S. Paglialunga, Paul M. Newberne, & Gerald N. Wogan. (1976). Transfer RNA methylase activity and capacity during aflatoxin B1-induced hepatocellular carcinogenesis.. PubMed. 36(6). 2013–8. 8 indexed citations
13.
Wogan, Gerald N., S. Paglialunga, Michael C. Archer, & Steven R. Tannenbaum. (1975). Carcinogenicity of nitrosation products of ephedrine, sarcosine, folic acid, and creatinine.. PubMed. 35(8). 1981–4. 41 indexed citations
14.
Büchi, G., D. Spitzner, S. Paglialunga, & Gerald N. Wogan. (1973). Synthesis and toxicity evaluation of aflatoxin P1. Life Sciences. 13(8). 1143–1149. 14 indexed citations
15.
Prinò, G, et al.. (1972). A sulfate glycopeptide (GLPS) as inhibitor of histamine gastric and duodenal ulcers. European Journal of Pharmacology. 17(2). 279–282. 5 indexed citations
16.
Prinò, G, et al.. (1971). Inhibition of experimentally-induced gastric ulcers in the rat by a new sulfated glycopeptide. European Journal of Pharmacology. 15(1). 119–126. 31 indexed citations
17.
Prinò, G, et al.. (1971). Inhibition of gastric peptic activity by a new sulfate glycopeptide (GLPS).. PubMed. 21(7). 918–21. 10 indexed citations
18.
Jori, A., S. Paglialunga, & Silvio Garattini. (1967). Effect of antidepressant and adrenergic blocking drugs on hyperthermia induced by reserpine.. PubMed. 165(2). 384–93. 14 indexed citations
19.
Jori, A. & S. Paglialunga. (1966). A Method to Record Body Temperature in Rats. Pharmacology. 14(6). 513–516. 3 indexed citations
20.
Jori, A., S. Paglialunga, & Silvio Garattini. (1966). Adrenergic mediation in the antagonism between desipramine and reserpine. Journal of Pharmacy and Pharmacology. 18(5). 326–327. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026